Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank75
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-20.59M
↑ 65% vs avg
Percentile
P75
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-59.36M
Historical baseline
PeriodValueYoY Change
TTM$-20.59M+79.7%
2024$-101.37M+11.7%
2023$-114.77M-10.0%
2022$-104.36M-21.3%
2021$-86.06M-62.3%
2020$-53.04M-48.7%
2019$-35.68M-179.1%
2018$-12.78M-130.1%
2017$-5.55M-